A synthetic peptide for use as a blocking control in assays to test for specificity of WNT16 antibody, Alternative Names: WNT16 control peptide, WNT16 antibody Blocking Peptide, Anti-WNT16 Blocking Peptide, Wingless-Type Mmtv Integration Site Family Member 16 Blocking Peptide, WNT16, WNT-16, WNT 16, WNT-16 Blocking Peptide, WNT 16 Blocking Peptide
WNT16
Reactivité: Humain, Singe, Lapin
Hôte: Synthetic
BP
Indications d'application
Optimal conditions should be determined by the investigator
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles.
Stock
-20 °C
Stockage commentaire
Store at -20 °C long term.
Antigène
WNT16
(Wingless-Type MMTV Integration Site Family, Member 16 (WNT16))
Synonymes
zgc:77293 Peptide, E130309I19Rik Peptide, Wnt family member 16 Peptide, wingless-type MMTV integration site family, member 16 Peptide, WNT16 Peptide, wnt16 Peptide, Wnt16 Peptide
Sujet
WNT proteins are secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. WNT16 contains two transcript variants diverging at the 5' termini. These two variants are proposed to be the products of separate promoters and not to be splice variants from a single promoter. They are differentially expressed in normal tissues, one of which (variant 2) is expressed at significant levels only in the pancreas, whereas another one (variant 1) is expressed more ubiquitously with highest levels in adult kidney, placenta, brain, heart, and spleen.